Intelligent Net Working Capital from 2010 to 2024
| INBS Stock | USD 2.38 0.04 1.71% |
Net Working Capital | First Reported 2010-12-31 | Previous Quarter -2.3 M | Current Value -2.2 M | Quarterly Volatility 5.3 M |
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.6 K, Interest Expense of 6.4 K or Selling General Administrative of 4 M, as well as many exotic indicators such as Price To Sales Ratio of 29.14, Dividend Yield of 0.0 or PTB Ratio of 8.34. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
Intelligent | Net Working Capital |
Latest Intelligent Bio's Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Intelligent Bio Solutions over the last few years. It is Intelligent Bio's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Intelligent Net Working Capital Regression Statistics
| Arithmetic Mean | (1,797,925) | |
| Coefficient Of Variation | (292.17) | |
| Mean Deviation | 3,243,364 | |
| Median | (3,977,138) | |
| Standard Deviation | 5,253,036 | |
| Sample Variance | 27.6T | |
| Range | 19.9M | |
| R-Value | 0.38 | |
| Mean Square Error | 25.4T | |
| R-Squared | 0.15 | |
| Significance | 0.16 | |
| Slope | 448,453 | |
| Total Sum of Squares | 386.3T |
Intelligent Net Working Capital History
About Intelligent Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Intelligent Bio income statement, its balance sheet, and the statement of cash flows. Intelligent Bio investors use historical funamental indicators, such as Intelligent Bio's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may use each financial statement separately, they are all related. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Intelligent Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Intelligent Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Intelligent Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | -2.3 M | -2.2 M |
Pair Trading with Intelligent Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intelligent Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intelligent Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Intelligent Stock
| 0.9 | DOCS | Doximity Financial Report 21st of May 2024 | PairCorr |
| 0.81 | VEEV | Veeva Systems Class Financial Report 29th of May 2024 | PairCorr |
| 0.79 | ENSG | Ensign Group | PairCorr |
Moving against Intelligent Stock
| 0.86 | HAE | Haemonetics | PairCorr |
| 0.85 | EHC | Encompass Health Corp | PairCorr |
| 0.79 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
| 0.41 | DVA | DaVita HealthCare | PairCorr |
The ability to find closely correlated positions to Intelligent Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intelligent Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intelligent Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intelligent Bio Solutions to buy it.
The correlation of Intelligent Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intelligent Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intelligent Bio Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intelligent Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Intelligent Bio Correlation against competitors. Note that the Intelligent Bio Solutions information on this page should be used as a complementary analysis to other Intelligent Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Intelligent Stock analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Intelligent Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intelligent Bio. If investors know Intelligent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intelligent Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (29.56) | Revenue Per Share 3.292 | Quarterly Revenue Growth 0.802 | Return On Assets (0.46) | Return On Equity (1.19) |
The market value of Intelligent Bio Solutions is measured differently than its book value, which is the value of Intelligent that is recorded on the company's balance sheet. Investors also form their own opinion of Intelligent Bio's value that differs from its market value or its book value, called intrinsic value, which is Intelligent Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intelligent Bio's market value can be influenced by many factors that don't directly affect Intelligent Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intelligent Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intelligent Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intelligent Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.